IL17A and chronic obstructive pulmonary disease: (2014) (28) demonstrated an increase in inflammatory (IL-17 and TNF-α) and anti-inflammatory (IL-10 and TGF-β) cytokines in patients with exacerbated COPD, in addition to an increase in Treg cells.